PRESS RELEASE
3 September 2026

Butler Snow Secures Summary Judgment For Teva In New Jersey Product Liability Litigation

BS
Butler Snow LLP

Contributor

Butler Snow LLP is a full-service law firm with more than 360 attorneys and advisors collaborating across a network of 27 offices in the United States, Europe and Asia. Butler Snow attorneys serve clients across more than 70 areas of law, representing clients from Fortune 500 companies to emerging start-ups
Butler Snow attorneys achieved a complete defense victory for Teva Pharmaceuticals in New Jersey product liability litigation involving the Paragard intrauterine device, with the court granting summary judgment and dismissing all claims with prejudice.
United States

Butler Snow attorneys secured a complete defense victory for Teva Pharmaceuticals USA, Inc., Teva Women’s Health, Inc., and Teva Women’s Health, LLC in a New Jersey product liability action involving the Paragard® intrauterine device. The court granted summary judgment in Teva’s favor and dismissed the plaintiff’s claims with prejudice. In doing so, the court found that the plaintiff’s failure-to-warn and design defect claims were preempted by federal law and independently failed under New Jersey law. The court also granted in part Teva’s motion for discovery sanctions, barring the plaintiff’s general liability experts from testifying.

Pamela L. Ferrell and Jordan N. Walker led Teva’s defense on the matter, with Walker arguing Teva’s sanctions motion and motion for summary judgment. Kyle R. Cummins, Charles A. (Chad) Byrd, and M. Elizabeth Roper handled the briefing. Greg Coates of Greenberg Traurig served as New Jersey counsel and argued Teva’s motion to exclude the plaintiff’s case-specific expert, Dr. Richard Luciani.

Contributor

Butler Snow LLP is a full-service law firm with more than 360 attorneys and advisors collaborating across a network of 27 offices in the United States, Europe and Asia. Butler Snow attorneys serve clients across more than 70 areas of law, representing clients from Fortune 500 companies to emerging start-ups

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More